Tachyon Therapeutics Email Format
Biotechnology ResearchCalifornia, United States0-1 Employees
Based in San Francisco, Tachyon Therapeutics operates in the biotechnology research industry, focusing on developing first-in-class cancer therapeutics that target novel biology. With a dedicated internal core development team and a broad external network of experts, the company advances its programs with speed, innovation, quality, and scientific integrity. Its work centers on advancing therapeutics against significant new drug targets in cancer biology. In August 2022, the U.S. FDA cleared Tachyon's Investigational New Drug application to develop TACH101 for the treatment of advanced solid tumors. The company maintains a very small team and is based in San Francisco, operating within the biotechnology research field.